KEGG pathway analyses exhibited that HHLA2 could potentially impact cancer etiology or pathogenesis in high HHLA2 expression groups, including Alzheimer's disease in BRCA; amino sugar and nucleotide sugar metabolism in COAD; and regulation of actin cytoskeleton in HNSC. This evidence concerns the gene HHLA2 and Alzheimer disease.